Study On The Effect Of Tiktaka Ghrita Tarpana,Prasadana Putapaka, Kataka Khadiradi Ghana Vati In Diabetic Retinopathy

Phase 2

Not yet recruiting

• Conditions: Retinal disorders in diseases classified elsewhere,

• Registration Number: CTRI/2020/03/024341
• Lead Sponsor: Director National Institute of Ayurveda

Brief Summary

This trial will be done to evaluate clinical efficacy of *Kataka Khadiradi kashaya* which has mentioned for all types of *Prameha*.  In order to make it palatable and easy to administer the same kashaya is made in the form of Ghan vati in the dose of 500 mg orally to control madhumeha which is the primary disease.

Hence in one group only oral medicine, K*ataka Khadiradi Ghan Vati*is advised to prove the efficacy of oral therapy

The second group will be given  K*ataka Khadiradi Ghan Vati* along with *Tarpana* a local treatment with *Tiktaka Ghrita.*

Third group will be given  K*ataka Khadiradi Ghan Vati*along with *Tarpana*a local treatment with *Tiktaka Ghrita* and *Prasadana Putapaka* to show the significant effect of *KriyaKalpa* procedures.

1 month research and 1 month follow up after treatment will be done within 15 days gap

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-04
• Last Update Posted: 2020-03-27

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Known cases of Type I and Type II diabetes mellitus 2.
• Patients with well controlled blood sugar level 3.
• Patients with visual symptoms like blurring of vision, floaters etc 4.
• Patients with mild to moderate NPDR 5.
• Patients willing to give written consent.

Exclusion Criteria

• Patients with severe NPDR or with PDR, Diabetic Maculopathy.
• Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitreal hemorrhage, RubiosisIridis.
• Gestational Diabetic Retinopathy.
• Severe visual impairments like high Myopia, Retinitis Pigmentosa, mature Cataract, post Cataract surgeries, Glaucoma.
• Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in Diabetic Retinopathy signs and symptoms as Blurred vision, Floaters and etc	2 Month

Secondary Outcome Measures

Name	Time	Method
Procedures might show effect in headache, other eye problems such as Dry eye, Occular Stress, Concretions hence any associated incidental findings if found will be reported.	2 month

Trial Locations

Locations (1)

National Institute of Ayurveda; 🇮🇳 Jaipur, RAJASTHAN, India

National Institute of Ayurveda

🇮🇳Jaipur, RAJASTHAN, India

Dr K S S P Fernando

Principal investigator

9351248532

shivanthipalikaks@yahoo.com